{"id":209697,"date":"2026-08-18T12:24:54","date_gmt":"2026-08-18T06:54:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=209697"},"modified":"2026-08-18T12:25:49","modified_gmt":"2026-08-18T06:55:49","slug":"why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/","title":{"rendered":"Ind-Swift Laboratories Ltd. (INDSWFTLAB) Share Price Rises 8.68% as Small Cap Stock Gains Today"},"content":{"rendered":"<p style=\"margin-top: 0!important; margin-bottom: 0!important;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\">Ind-Swift Laboratories Ltd.<\/a> traded at Rs 340.5, up 8.68% today, taking its market capitalisation to Rs 2,645.37 crore and placing the small-cap pharma stock firmly in focus.<\/p>\n<p style=\"margin-top: 0!important;\">Ind-Swift Laboratories Ltd. Share Price moved sharply higher on 18 August 2026, with the stock trading at Rs 340.5, up Rs 27.2 or 8.68% from its previous close of Rs 313.3. At this price, the company\u2019s market capitalisation stood at Rs 2,645.37 crore, making it one of the notable small-cap names in today\u2019s Stock Market Today action. As of 18 August 2026 at 12:18:56 PM IST, the verified data confirmed the move, and this article was posted at 12:18:59 PM IST.<\/p>\n<p>For investors searching Ind-Swift Laboratories Ltd. Share Price Today, the key takeaway is straightforward: the stock delivered a strong single-session price rise backed by active volume and a firm intraday range. The available data confirms what happened in the market, but it does not establish a company-specific catalyst behind today\u2019s move. That matters because price action can be clear even when the exact trigger is not confirmed in the supplied company news set.<\/p>\n<p>Ind-Swift Laboratories Ltd. Stock News is therefore being driven today by the verified share price gain, trading activity and the fact that the move was meaningful enough to put the counter among market movers. For investors asking why the stock is trending, the data points to an 8.68% rise, total traded volume of 36,03,970 shares and turnover of Rs 5.37 crore. Important financial metrics also add context: the stock trades at a P\/E of 47.53 and P\/B of 1.82, while ROE is -0.78 and ROCE is 8.31. The next things to monitor are whether price action holds near the day\u2019s high, how valuation compares with peers, and whether sector context continues to support investor attention, as Univest tracks throughout the session.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Ind-Swift_Laboratories_Ltd_INDSWFTLAB_Share_Price_Today_Price_Action_Analysis\" title=\"Ind-Swift Laboratories Ltd. (INDSWFTLAB) Share Price Today: Price Action Analysis\">Ind-Swift Laboratories Ltd. (INDSWFTLAB) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Ind-Swift_Laboratories_Ltd_INDSWFTLAB_Fundamental_Analysis\" title=\"Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis\">Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Why_Investors_Are_Watching_Ind-Swift_Laboratories_Ltd\" title=\"Why Investors Are Watching Ind-Swift Laboratories Ltd.\">Why Investors Are Watching Ind-Swift Laboratories Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#About_Ind-Swift_Laboratories_Ltd\" title=\"About Ind-Swift Laboratories Ltd.\">About Ind-Swift Laboratories Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Track_Ind-Swift_Laboratories_Ltd_Share_Price_on_Univest\" title=\"Track Ind-Swift Laboratories Ltd. Share Price on Univest\">Track Ind-Swift Laboratories Ltd. Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#What_is_Ind-Swift_Laboratories_Ltd_Share_Price_today\" title=\"What is Ind-Swift Laboratories Ltd. Share Price today?\">What is Ind-Swift Laboratories Ltd. Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Why_is_Ind-Swift_Laboratories_Ltd_rising_today\" title=\"Why is Ind-Swift Laboratories Ltd. rising today?\">Why is Ind-Swift Laboratories Ltd. rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#What_was_the_intraday_range_for_Ind-Swift_Laboratories_Ltd_today\" title=\"What was the intraday range for Ind-Swift Laboratories Ltd. today?\">What was the intraday range for Ind-Swift Laboratories Ltd. today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Is_Ind-Swift_Laboratories_Ltd_a_small-cap_stock\" title=\"Is Ind-Swift Laboratories Ltd. a small-cap stock?\">Is Ind-Swift Laboratories Ltd. a small-cap stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#How_much_volume_was_traded_in_Ind-Swift_Laboratories_Ltd_today\" title=\"How much volume was traded in Ind-Swift Laboratories Ltd. today?\">How much volume was traded in Ind-Swift Laboratories Ltd. today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#What_does_the_valuation_of_Ind-Swift_Laboratories_Ltd_look_like\" title=\"What does the valuation of Ind-Swift Laboratories Ltd. look like?\">What does the valuation of Ind-Swift Laboratories Ltd. look like?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#How_profitable_is_Ind-Swift_Laboratories_Ltd_compared_with_its_industry\" title=\"How profitable is Ind-Swift Laboratories Ltd. compared with its industry?\">How profitable is Ind-Swift Laboratories Ltd. compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#Does_Ind-Swift_Laboratories_Ltd_pay_a_dividend\" title=\"Does Ind-Swift Laboratories Ltd. pay a dividend?\">Does Ind-Swift Laboratories Ltd. pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#How_does_Ind-Swift_Laboratories_Ltd_compare_with_peers_on_market_cap\" title=\"How does Ind-Swift Laboratories Ltd. compare with peers on market cap?\">How does Ind-Swift Laboratories Ltd. compare with peers on market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-ind-swift-laboratories-ltd-share-price-rise-2026-08-18\/#What_should_investors_monitor_next_in_Ind-Swift_Laboratories_Ltd\" title=\"What should investors monitor next in Ind-Swift Laboratories Ltd.?\">What should investors monitor next in Ind-Swift Laboratories Ltd.?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Ind-Swift_Laboratories_Ltd_INDSWFTLAB_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Ind-Swift Laboratories Ltd. (INDSWFTLAB) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0 22px 0;\">\n<tbody>\n<tr>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 10px 12px; background: #F7F9FC;\">Metric<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 10px 12px; background: #F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 340.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 313.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Today&#8217;s Change<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">+Rs 27.2 (+8.68%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 319.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 343.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 318.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">1,57,603<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">1,57,603<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">34,46,367<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">36,03,970<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 5.37 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 2,645.37 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Small Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLAB) traded at Rs 340.5. versus the previous close of Rs 313.3, a rise of 8.68%. The stock opened at Rs 319.75, reached Rs 343.25, touched Rs 318.1. Reported volume was 1,57,603.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Ind-Swift_Laboratories_Ltd_INDSWFTLAB_Fundamental_Analysis\"><\/span><strong>Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0 22px 0;\">\n<tbody>\n<tr>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 10px 12px; background: #F7F9FC;\">Metric<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 10px 12px; background: #F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 2,645.37 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">47.53x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">1.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">8.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 6.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. was valued at a P\/E ratio of 47.53x, a P\/B ratio of 1.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs 6.59, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<p>Ind-Swift Laboratories Ltd. Fundamental Analysis shows a business that is now attracting attention because of price action, but the financial ratios present a mixed picture. Valuation is not low versus the industry median on the supplied numbers, while profitability metrics remain below broader healthcare benchmarks. That makes the current move notable, but it also means investors should read today\u2019s strength alongside the company\u2019s exact financial profile.<\/p>\n<p>At Rs 2,645.37 crore in market capitalisation, Ind-Swift Laboratories Ltd. sits well above the industry median market cap of Rs 142.37 crore and the industry average of Rs 492.43 crore in the supplied same-industry benchmark universe of 136 companies. Market capitalisation, however, only signals size and market value; it does not itself confirm business quality. On valuation, the company\u2019s P\/E ratio of 47.53 is above the industry median of 26.24 and above the industry average of 39.98, though still far below the maximum observed P\/E of 359.13 in the benchmark set. The industry P\/E range itself runs from 2.96 to 359.13 across 105 companies.<\/p>\n<p>The stock\u2019s P\/B ratio is 1.82, exactly in line with the industry median of 1.82 and below the industry average of 2.49. That places Ind-Swift Laboratories Ltd. Share Price at a book-value multiple that looks more moderate than its earnings multiple. EPS stands at 6.59, which means the current price reflects roughly 47.53 times earnings per share on the supplied data. Dividend yield is 0, so the stock is currently not offering a meaningful historical cash-yield cushion through dividends.<\/p>\n<p>Profitability remains an important point of context. ROE is -0.78, below the industry median of 10.49 and below the industry average of 8.1, which indicates that shareholder returns on the latest supplied basis are weak relative to peers. ROCE is 8.31, also below the industry median of 12.97 and below the industry average of 15.53. In other words, Ind-Swift Laboratories Ltd. Stock Analysis today is being pulled by momentum and price action more than by standout profitability numbers. For readers following Ind-Swift Laboratories Ltd. Financial Results and Ind-Swift Laboratories Ltd. Earnings, that combination makes ownership and peer context especially important, even when the latest move is attracting immediate attention on Univest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0 22px 0;\">\n<tbody>\n<tr>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 10px 12px; background: #F7F9FC;\">Metric<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 10px 12px; background: #F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">47.53x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">26.24x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">39.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">2.96x to 359.13x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">1.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">1.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">10.49%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">8.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">12.97%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 2,645.37 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 10px 12px;\">Rs 142.37 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P\/E ratio of 47.53x, which is above the benchmark median of 26.24x, a difference of +81.14%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of -0.78%, which is below the benchmark median of 10.49%, a difference of -107.44%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 8.31%, which is below the benchmark median of 12.97%, a difference of -35.93%.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>The healthcare and pharmaceuticals backdrop gives useful context for today\u2019s move. Ind-Swift Laboratories Ltd. operates in Healthcare within the Pharmaceuticals &amp; Drugs industry, and the supplied benchmark compares it with 136 companies from the same industry. Relative positioning matters here because the company\u2019s valuation and profitability sit in different places versus the benchmark.<\/p>\n<p>Within the same-industry dataset, Ind-Swift Laboratories Ltd. Share Price reflects a company whose P\/E ratio of 47.53 is above both the benchmark median of 26.24 and the benchmark average of 39.98. That suggests the stock is trading at a richer earnings multiple than the middle of the industry pack, though not near the most expensive end because the benchmark maximum reaches 359.13. The company\u2019s P\/B ratio of 1.82 matches the industry median exactly and sits below the industry average of 2.49, while the broader P\/B range runs from -11.02 to 16.76 across 135 companies.<\/p>\n<p>Profitability comparisons are less favourable. The company\u2019s ROE of -0.78 is below the benchmark median of 10.49 and also below the average of 8.1. ROCE at 8.31 is lower than the median of 12.97 and average of 15.53. Those numbers show that while the market is currently rewarding the stock with a sharp price rise, the business is not screening as a profitability leader versus the Pharmaceuticals &amp; Drugs group on the supplied snapshot.<\/p>\n<p>Size is one area where the company stands out. Its market capitalisation of Rs 2,645.37 crore is much higher than the benchmark median of Rs 142.37 crore and well above the average of Rs 492.43 crore, although still below the benchmark maximum of Rs 2,985.15 crore. The benchmark minimum market cap is Rs 6.06 crore. So in sector terms, Ind-Swift Laboratories Ltd. Latest News today is tied to a stock that is relatively large within its industry sample, moderately priced on book value, more expensive on earnings, and weaker than benchmark medians on ROE and ROCE. That mix helps explain why the counter is being watched closely on Univest and across broader Share Market Today screens.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0 22px 0;\">\n<tbody>\n<tr>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 8px; background: #F7F9FC;\">Company<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 8px; background: #F7F9FC;\">Symbol<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 8px; background: #F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 8px; background: #F7F9FC;\">P\/E<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 8px; background: #F7F9FC;\">P\/B<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 8px; background: #F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align: left; border: 1px solid #E3E7EE; padding: 8px; background: #F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">DCAL<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">2,985.15<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">170.32<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">0.42<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">-2.89<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">BETA<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">2,827.67<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">65.02<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">10.29<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">18.65<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">HIKAL<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">2,686.72<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">0<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">2.2<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">15.22<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\"><strong>Fredun Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">FREDUN<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">2,559.68<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">54.85<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">8.19<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">11.42<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">13.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\"><a href=\"https:\/\/univest.in\/stocks\/solara\/solara-active-pharma-sciences-ltd-share-price-today\"><strong>Solara Active Pharma Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">SOLARA<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">2,465.73<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">0<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">1.93<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">17.23<\/td>\n<td style=\"border: 1px solid #E3E7EE; padding: 8px;\">15.34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P\/E ratio of 47.53x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 2,645.37 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<p>Peer comparison shows Ind-Swift Laboratories Ltd. positioned among similarly sized listed pharmaceuticals companies, but with mixed relative metrics. Its market cap of Rs 2,645.37 crore places it near Hikal Ltd. at Rs 2,686.72 crore, Beta Drugs Ltd. at Rs 2,827.67 crore and Dishman Carbogen Amcis Ltd. at Rs 2,985.15 crore, while still above Fredun Pharmaceuticals Ltd. at Rs 2,559.68 crore, Solara Active Pharma Sciences Ltd. at Rs 2,465.73 crore, Sai Parenteral&#8217;s Ltd. at Rs 2,438.25 crore, Panacea Biotec Ltd. at Rs 2,429.2 crore, Venus Remedies Ltd. at Rs 2,388.41 crore and NGL Fine-Chem Ltd. at Rs 2,139.2 crore.<\/p>\n<p>On valuation, Ind-Swift Laboratories Ltd. Share Price carries a P\/E of 47.53. That is lower than Dishman Carbogen Amcis at 170.32, Sai Parenteral&#8217;s at 170.53, Beta Drugs at 65.02 and Fredun Pharmaceuticals at 54.85, but higher than Venus Remedies at 20.48 and NGL Fine-Chem at 31.64. Hikal, Solara and Panacea do not have a supplied peer P\/E figure in this dataset, so the most direct takeaway is that Ind-Swift sits in the middle of the available P\/E range among named peers rather than at an extreme.<\/p>\n<p>Its P\/B of 1.82 is above Dishman\u2019s 0.42 but below Hikal\u2019s 2.2, Solara\u2019s 1.93, Panacea\u2019s 3.02, Sai Parenteral&#8217;s 3.12, Venus Remedies\u2019 3.47, NGL Fine-Chem\u2019s 5.21, Fredun\u2019s 8.19 and Beta Drugs\u2019 10.29. Profitability is where the gap is clearest. Ind-Swift\u2019s ROE of -0.78 trails Beta Drugs at 18.65, Hikal at 15.22, Fredun at 11.42, Solara at 17.23, Sai Parenteral&#8217;s at 13.9, Venus Remedies at 9.85 and NGL Fine-Chem at 27.9; it is only above Dishman\u2019s -2.89 and below Panacea\u2019s 0. ROCE of 8.31 is also below most peers, exceeding only Dishman\u2019s -0.26 and Panacea\u2019s 5.36 while trailing Beta\u2019s 22.17, Hikal\u2019s 16.15, Fredun\u2019s 13.15, Solara\u2019s 15.34, Sai Parenteral&#8217;s 12.97 and NGL Fine-Chem\u2019s 33.91. That makes the current share price rise especially interesting because it has arrived despite less impressive profitability metrics than many peers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Ind-Swift_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Ind-Swift Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are watching Ind-Swift Laboratories Ltd. Share Price because today\u2019s move combines strong intraday gains, a close-to-high trading pattern and meaningful activity across NSE and BSE. The stock has also moved into a zone where valuation, profitability and peer comparison all deserve closer attention. For traders and long-term market watchers alike, this is the kind of session that can elevate a stock from routine tracking into active discussion within Stocks in News and Top Gainers Today lists on Univest.<\/p>\n<ul>\n<li><strong>Verified price action:<\/strong> the stock rose 8.68% to Rs 340.5 from Rs 313.3.<\/li>\n<li><strong>Intraday strength:<\/strong> price traded between Rs 318.1 and Rs 343.25, staying near the high.<\/li>\n<li><strong>Trading activity:<\/strong> total volume reached 36,03,970 shares, with 34,46,367 on NSE and 1,57,603 on BSE.<\/li>\n<li><strong>Valuation context:<\/strong> P\/E is 47.53 and P\/B is 1.82.<\/li>\n<li><strong>Profitability context:<\/strong> ROE is -0.78 and ROCE is 8.31.<\/li>\n<li><strong>Sector position:<\/strong> market cap of Rs 2,645.37 crore is well above the industry median.<\/li>\n<\/ul>\n<p>What investors may monitor next is whether Ind-Swift Laboratories Ltd. Share Price continues to hold above the opening level of Rs 319.75, whether turnover remains supportive, and how the stock\u2019s richer-than-median P\/E interacts with weaker-than-median ROE and ROCE. In the absence of a verified company-specific trigger in the supplied data, the durability of price action and its alignment with broader Pharmaceuticals &amp; Drugs positioning become the main variables to track.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Ind-Swift_Laboratories_Ltd\"><\/span><strong>About Ind-Swift Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ind-Swift Laboratories Ltd. is positioned within the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. That means the stock is being assessed by the market alongside other listed drug and pharmaceutical businesses where valuation, profitability, scale and capital efficiency are closely watched. In today\u2019s market context, Ind-Swift Laboratories Ltd. Share Price is not only being discussed as a momentum name but also as a sector stock that sits near the larger end of its same-industry benchmark universe.<\/p>\n<p>Based on the supplied benchmark set, the company\u2019s market capitalisation of Rs 2,645.37 crore places it above the industry average and far above the median, which suggests it is materially larger than a typical company in this specific comparison group. Nearby listed names by market value include Hikal Ltd., Beta Drugs Ltd., Fredun Pharmaceuticals Ltd. and Solara Active Pharma Sciences Ltd. That places Ind-Swift in a competitive listed cluster where investors often compare P\/E, P\/B, ROE and ROCE alongside daily Stock Performance.<\/p>\n<p>For readers following Ind-Swift Laboratories Ltd. Company News, the most useful business takeaway from the supplied data is that the company belongs to a sector where peer dispersion is wide. In this industry sample, valuation multiples range sharply and profitability outcomes differ meaningfully across companies. That is why both the price rise and the underlying financial ratios matter when assessing Ind-Swift Laboratories Ltd. Share News in the Indian Stock Market.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Ind-Swift_Laboratories_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Ind-Swift Laboratories Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\">Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Readers tracking Ind-Swift Laboratories Ltd. Share Price can use Univest to follow live share price moves, intraday price action, market cap changes and broader stock analysis in one place. For stocks appearing in top gainer screens, Univest helps users monitor price, turnover, exchange-wise volume, sector context and peer positioning without separating market data from company ratios.<\/p>\n<p>Beyond today\u2019s move, Univest also helps investors track Ind-Swift Laboratories Ltd. Share Price Today alongside valuation metrics such as P\/E and P\/B, profitability indicators like ROE and ROCE, 52-week levels when available, and broader market insights relevant to NSE News and BSE News. For users following Ind-Swift Laboratories Ltd. Stock News and Ind-Swift Laboratories Ltd. Share Price Live developments, that combination can be useful in understanding whether a stock is moving on isolated momentum, sector rotation or a broader change in market attention.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Ind-Swift_Laboratories_Ltd_Share_Price_today\"><\/span><strong>What is Ind-Swift Laboratories Ltd. Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ind-Swift Laboratories Ltd. Share Price was Rs 340.5 on 18 August 2026 at the time of the update. The stock was up Rs 27.2 from the previous close of Rs 313.3, translating into a gain of 8.68%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Ind-Swift_Laboratories_Ltd_rising_today\"><\/span><strong>Why is Ind-Swift Laboratories Ltd. rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Ind-Swift Laboratories Ltd. rose 8.68% today with total traded volume of 36,03,970 shares and turnover of Rs 5.37 crore. However, the verified dataset does not establish a company-specific catalyst behind the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_intraday_range_for_Ind-Swift_Laboratories_Ltd_today\"><\/span><strong>What was the intraday range for Ind-Swift Laboratories Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock opened at Rs 319.75, touched an intraday high of Rs 343.25 and a low of Rs 318.1. Trading near Rs 340.5 means Ind-Swift Laboratories Ltd. held close to the upper end of its day\u2019s range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Ind-Swift_Laboratories_Ltd_a_small-cap_stock\"><\/span><strong>Is Ind-Swift Laboratories Ltd. a small-cap stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, the supplied classification places Ind-Swift Laboratories Ltd. in the Small Cap category. Its market capitalisation stood at Rs 2,645.37 crore during today\u2019s session, which is the key size reference used in this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_volume_was_traded_in_Ind-Swift_Laboratories_Ltd_today\"><\/span><strong>How much volume was traded in Ind-Swift Laboratories Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Total traded volume in Ind-Swift Laboratories Ltd. was 36,03,970 shares. Of this, NSE volume was 34,46,367 shares and BSE volume was 1,57,603 shares, showing that most of today\u2019s activity was concentrated on the NSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_valuation_of_Ind-Swift_Laboratories_Ltd_look_like\"><\/span><strong>What does the valuation of Ind-Swift Laboratories Ltd. look like?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ind-Swift Laboratories Ltd. trades at a P\/E ratio of 47.53 and a P\/B ratio of 1.82. Its P\/E is above the same-industry median of 26.24, while its P\/B is exactly in line with the benchmark median of 1.82.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Ind-Swift_Laboratories_Ltd_compared_with_its_industry\"><\/span><strong>How profitable is Ind-Swift Laboratories Ltd. compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s ROE is -0.78 and ROCE is 8.31. Both metrics are below the same-industry medians of 10.49 for ROE and 12.97 for ROCE, indicating weaker profitability than the benchmark midpoint.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Ind-Swift_Laboratories_Ltd_pay_a_dividend\"><\/span><strong>Does Ind-Swift Laboratories Ltd. pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied dividend yield for Ind-Swift Laboratories Ltd. is 0. That means the current dataset does not show a meaningful historical dividend yield contribution to the stock\u2019s present market pricing or investor return profile.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Ind-Swift_Laboratories_Ltd_compare_with_peers_on_market_cap\"><\/span><strong>How does Ind-Swift Laboratories Ltd. compare with peers on market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> With a market capitalisation of Rs 2,645.37 crore, Ind-Swift Laboratories Ltd. sits close to Hikal at Rs 2,686.72 crore and below Dishman Carbogen Amcis at Rs 2,985.15 crore, while remaining above several other named pharmaceutical peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Ind-Swift_Laboratories_Ltd\"><\/span><strong>What should investors monitor next in Ind-Swift Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors may watch whether Ind-Swift Laboratories Ltd. holds above its opening price of Rs 319.75, whether volume stays elevated after today\u2019s 8.68% rise, and how its higher P\/E interacts with weaker ROE and ROCE versus industry benchmarks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ind-Swift Laboratories Ltd. Share Price rises to Rs Rs 340.5. marking a 8.68% rise today. clearing the 8% threshold for Small Cap stocks. Market cap stands at<\/p>\n","protected":false},"author":36,"featured_media":209695,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-209697","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["209695"],"_edit_lock":["1787036151:36"],"rank_math_title":["Ind-Swift Laboratories Ltd. Share Price Rises 8.68% Today"],"rank_math_description":["Ind-Swift Laboratories Ltd. Share Price posted a strong gain today. Check price action, fundamentals, sector benchmark and peer positioning."],"rank_math_focus_keyword":["Ind-Swift Laboratories Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["68"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["38450"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Ind_Swift_Laboratories_Ltd_INDSWFTLAB_Share_Price_Rises_868_as_Small_Cap_Stock_Gains_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/209697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=209697"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/209697\/revisions"}],"predecessor-version":[{"id":209705,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/209697\/revisions\/209705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/209695"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=209697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=209697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=209697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}